Coherus Oncology, Inc. (CHRS)
1.13
-0.04
(-3.42%)
USD |
NASDAQ |
Sep 25, 16:00
1.15
+0.02
(+1.77%)
After-Hours: 19:59
Coherus Oncology Net Income (Annual) : -183.12M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -183.12M |
| December 31, 2024 | -215.39M |
| December 31, 2023 | -237.89M |
| December 31, 2022 | -291.75M |
| December 31, 2021 | -287.10M |
| December 31, 2020 | 132.24M |
| December 31, 2019 | 89.83M |
| Date | Value |
|---|---|
| December 31, 2018 | -209.41M |
| December 31, 2017 | -238.29M |
| December 31, 2016 | -127.79M |
| December 31, 2015 | -223.94M |
| December 31, 2014 | -87.18M |
| December 31, 2013 | -53.64M |
| December 31, 2012 | -33.02M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Enanta Pharmaceuticals, Inc. | -81.89M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |
| Savara, Inc. | -118.84M |